Gilder Gagnon Howe & CO LLC Burning Rock Biotech LTD Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $142,949 - $259,825	-15,159 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.37 - $27.92 $11.7 Million - $18.7 Million	-671,476 Reduced 97.79%	15,159 $271,000
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $39,131 - $56,062	-1,497 Reduced 0.22%	686,635 $20.2 Million
Q1 2021 May 17, 2021	BUY	$23.5 - $39.58 $16 Million - $26.9 Million	679,406 Added 7786.0%	688,132 $18.5 Million
Q4 2020 Feb 16, 2021	BUY	$22.55 - $30.87 $167,456 - $229,240	7,426 Added 571.23%	8,726 $202,000
Q3 2020 Nov 16, 2020	SELL	$19.07 - $29.61 $15,866 - $24,635	-832 Reduced 39.02%	1,300 $33,000
Q2 2020 Aug 14, 2020	BUY	$23.21 - $31.43 $49,483 - $67,008	2,132 New	2,132 $58,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.